Normalization of real-time quantitative reverse transcription-PCR knowledge: a model-based variance estimation method to establish genes fitted to normalization, utilized to bladder and colon most cancers knowledge units.
- Correct normalization is an absolute prerequisite for proper measurement of gene expression. For quantitative real-time reverse transcription-PCR (RT-PCR), essentially the most generally used normalization technique includes standardization to a single constitutively expressed management gene. Nonetheless, lately, it has grow to be clear that no single gene is constitutively expressed in all cell varieties and beneath all experimental circumstances, implying that the expression stability of the meant management gene needs to be verified earlier than every experiment.
METASTASIS ASSOCIATED IN COLON CANCER 1 (MACC1) MONOCLONAL ANTIBODY (HUMAN)
- We define a novel, modern, and sturdy technique to establish stably expressed genes amongst a set of candidate normalization genes. The technique is rooted in a mathematical mannequin of gene expression that allows estimation not solely of the general variation of the candidate normalization genes but in addition of the variation wagerween pattern subgroups of the pattern set.
- Notably, the technique offers a direct measure for the estimated expression variation, enabling the person to evaluate the systematic error launched when utilizing the gene.
PIG CANCER/TESTIS ANTIGEN 1(CTAG1A) ELISA KIT
- In a side-by-side comparability with a beforehand revealed technique, our model-based method carried out in a extra sturdy method and confirmed much less sensitivity towards coregulation of the candidate normalization genes. We used the model-based technique to establish genes suited to normalize quantitative RT-PCR knowledge from colon most cancers and bladder most cancers.
- These genes are UBC, GAPD, and TPT1 for the colon and HSPCB, TEGT, and ATP5B for the bladder. The offered technique might be utilized to judge the suitability of any normalization gene candidate in any form of experimental design and will enable extra dependable normalization of RT-PCR knowledge.
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody |
|||
| CAU29898-100ul | Biomatik Corporation | 100ul | EUR 272.6 |
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody |
|||
| CAU29898-200ul | Biomatik Corporation | 200ul | EUR 341 |
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human) |
|||
| 4-MAM667Hu21 | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), PE |
|||
| 4-MAM667Hu21-PE | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), APC |
|||
| 4-MAM667Hu21-APC | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), Cy3 |
|||
| 4-MAM667Hu21-Cy3 | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), FITC |
|||
| 4-MAM667Hu21-FITC | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), HRP |
|||
| 4-MAM667Hu21-HRP | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), APC-Cy7 |
|||
| 4-MAM667Hu21-APC-Cy7 | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Monoclonal Antibody (Human), Biotinylated |
|||
| 4-MAM667Hu21-Biotin | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx104134 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx121640 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx132298 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx210666 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx210667 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx234920-100ug | Abbexa | 100 ug | EUR 610.8 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx242861 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx338434 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| 20-abx325504 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx104134-100g | Abbexa | 100 µg | EUR 825 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx104134-20g | Abbexa | 20 µg | EUR 287.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx104134-50g | Abbexa | 50 µg | EUR 362.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx210666-100l | Abbexa | 100 µl | EUR 350 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx210666-50l | Abbexa | 50 µl | EUR 250 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx210667-100l | Abbexa | 100 µl | EUR 350 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx210667-50l | Abbexa | 50 µl | EUR 250 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx234920-100g | Abbexa | 100 µg | EUR 350 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx242861-96tests | Abbexa | 96 tests | EUR 612.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx132298-100tests | Abbexa | 100 tests | EUR 300 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx325504-100g | Abbexa | 100 µg | EUR 250 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx325504-50g | Abbexa | 50 µg | EUR 187.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx338434-100g | Abbexa | 100 µg | EUR 162.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
|||
| abx375246-96tests | Abbexa | 96 tests | EUR 337.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (HRP) |
|||
| 20-abx336504 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (HRP) |
|||
| abx336504-100g | Abbexa | 100 µg | EUR 362.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (HRP) |
|||
| abx336504-20g | Abbexa | 20 µg | EUR 162.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (HRP) |
|||
| abx336504-50g | Abbexa | 50 µg | EUR 250 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (FITC) |
|||
| 20-abx336505 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (FITC) |
|||
| abx336505-100g | Abbexa | 100 µg | EUR 362.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (FITC) |
|||
| abx336505-20g | Abbexa | 20 µg | EUR 162.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (FITC) |
|||
| abx336505-50g | Abbexa | 50 µg | EUR 250 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (Biotin) |
|||
| 20-abx336506 | Abbexa |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (Biotin) |
|||
| abx336506-100g | Abbexa | 100 µg | EUR 362.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (Biotin) |
|||
| abx336506-20g | Abbexa | 20 µg | EUR 162.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (Biotin) |
|||
| abx336506-50g | Abbexa | 50 µg | EUR 250 |
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody |
|||
| CAU21293-100ul | Biomatik Corporation | 100ul | EUR 259.2 |
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody |
|||
| CAU21293-200ul | Biomatik Corporation | 200ul | EUR 324.2 |
Macc1 (untagged) - Mouse metastasis associated in colon cancer 1 (Macc1), (10ug) |
|||
| MC222082 | Origene Technologies GmbH | 10 µg | Ask for price |
Macc1 (untagged) - Rat metastasis associated in colon cancer 1 (Macc1) |
|||
| RN217262 | Origene Technologies GmbH | 10 µg | Ask for price |
Macc1 (GFP-tagged) - Mouse metastasis associated in colon cancer 1 (Macc1), (10ug) |
|||
| MG215441 | Origene Technologies GmbH | 10 µg | Ask for price |
Polyclonal Antibody to Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| PAM667Hu01 | Cloud-Clone | 100ul | EUR 270 |
MACC1 (untagged)-Human metastasis associated in colon cancer 1 (MACC1) |
|||
| SC307508 | Origene Technologies GmbH | 10 µg | Ask for price |
Macc1 (Myc-DDK-tagged) - Mouse metastasis associated in colon cancer 1 (Macc1) |
|||
| MR215441 | Origene Technologies GmbH | 10 µg | Ask for price |
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody (Human) |
|||
| 4-PAM667Hu01 | Cloud-Clone |
|
|
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| RPM667Hu01 | Cloud-Clone | 10ug | EUR 196 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| 4-RPM667Hu01 | Cloud-Clone |
|
|
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| RPM667Hu02 | Cloud-Clone | 10ug | EUR 198 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| RPU42748-100ug | Biomatik Corporation | 100ug | EUR 603.9 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| RPU42748-1mg | Biomatik Corporation | 1mg | EUR 2675.4 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| RPU42748-50ug | Biomatik Corporation | 50ug | EUR 485.1 |
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody (Human), PE |
|||
| 4-PAM667Hu01-PE | Cloud-Clone |
|
|
MACC1 (GFP-tagged) - Human metastasis associated in colon cancer 1 (MACC1) |
|||
| RG224774 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Metastasis Associated In Colon Cancer 1 (MACC1) Protein |
|||
| 20-abx068004 | Abbexa |
|
|
Human Metastasis Associated In Colon Cancer 1 (MACC1) Protein |
|||
| abx068004-200g | Abbexa | 200 µg | EUR 237.5 |
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody (Human), APC |
|||
| 4-PAM667Hu01-APC | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody (Human), Cy3 |
|||
| 4-PAM667Hu01-Cy3 | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody (Human), FITC |
|||
| 4-PAM667Hu01-FITC | Cloud-Clone |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Polyclonal Antibody (Human), HRP |
|||
| 4-PAM667Hu01-HRP | Cloud-Clone |
|
|
ELISA Kit for Metastasis Associated In Colon Cancer 1 (MACC1) |
|||
| SEM667Hu | Cloud-Clone | 96Т | EUR 770 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) CLIA Kit |
|||
| 20-abx496070 | Abbexa |
|
|
Macc1 (myc-DDK-tagged) - Rat metastasis associated in colon cancer 1 (Macc1) |
|||
| RR217262 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| 20-abx152254 | Abbexa |
|
|
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| abx251113-96tests | Abbexa | 96 tests | EUR 895.2 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| abx572579-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| DLR-MACC1-Hu | DL Develop | 96T | EUR 505 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| DLR-MACC1-Hu-48T | DL Develop | 48T | EUR 664.8 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| DLR-MACC1-Hu-96T | DL Develop | 96T | EUR 870 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| DL-MACC1-Hu | DL Develop | 96T | EUR 481 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EKN47037-48T | Biomatik Corporation | 48T | EUR 416.29 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EKN47037-5x96T | Biomatik Corporation | 5x96T | EUR 2824.83 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EKN47037-96T | Biomatik Corporation | 96T | EUR 594.7 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EK15325 | SAB | 96Т | EUR 768 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EKU05926-48T | Biomatik Corporation | 48T | EUR 610.82 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EKU05926-5x96T | Biomatik Corporation | 5x96T | EUR 4144.85 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| EKU05926-96T | Biomatik Corporation | 96T | EUR 872.6 |
Human Metastasis Associated In Colon Cancer 1(MACC1)ELISA Kit |
|||
| QY-E02795 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| RD-MACC1-Hu-48T | Reddot Biotech | 48T | EUR 493.5 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| RD-MACC1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 675.6 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| RD-MACC1-Hu-96T | Reddot Biotech | 96T | EUR 705 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
|||
| RD-MACC1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 939.6 |
Identification and enlargement of human colon–most cancers-initiating cells.
- Colon carcinoma is the second most typical reason for dying from most cancers. The isolation and characterization of tumorigenic colon most cancers cells could assist to plan novel diagnostic and therapeutic procedures.
METASTASIS ASSOCIATED IN COLON CANCER 1 (MACC1) ANTIBODY
- Though there may be rising proof {that a} uncommon inhabitants of undifferentiated cells is accountable for tumour formation and upkeep, this has not been explored for colorectal most cancers. Right here, we present that tumorigenic cells in colon most cancers are included within the high-density CD133+ inhabitants, which accounts for about 2.5% of the tumour cells.
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| CSB-YP006125HU | Cusabio | 5594 mg | Ask for price |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| CSB-EP006125HU | Cusabio | 914 mg | Ask for price |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| CSB-MP006125HU | Cusabio | 4904 mg | Ask for price |
Recombinant Human Cancer/testis antigen 1(CTAG1A) |
|||
| AP72513 | SAB | each | Ask for price |
Recombinant Human Cancer/testis antigen 1(CTAG1A) |
|||
| AP77401 | SAB | 1mg | EUR 1978 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC27218-100ug | Biomatik Corporation | 100ug | EUR 1931.2 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC27218-20ug | Biomatik Corporation | 20ug | EUR 726 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC21152-100ug | Biomatik Corporation | 100ug | EUR 460.9 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC21152-1mg | Biomatik Corporation | 1mg | EUR 2237.8 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC21152-20ug | Biomatik Corporation | 20ug | EUR 258.7 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC20225-100ug | Biomatik Corporation | 100ug | EUR 573.1 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
|||
| RPC20225-20ug | Biomatik Corporation | 20ug | EUR 288.8 |
Human Cancer/testis antigen 1 (CTAG1A) |
|||
| 1-CSB-YP006125HU | Cusabio |
|
|
Human Cancer/testis antigen 1 (CTAG1A) |
|||
| 1-CSB-EP006125HU | Cusabio |
|
|
CTAG1A (untagged)-Human cancer/testis antigen 1A (CTAG1A) |
|||
| SC306136 | Origene Technologies GmbH | 10 µg | Ask for price |
CTAG1A (GFP-tagged) - Human cancer/testis antigen 1A (CTAG1A) |
|||
| RG216285 | Origene Technologies GmbH | 10 µg | Ask for price |
Recombinant Human Cancer/testis antigen 2 (CTAG2) |
|||
| CSB-YP006127HUa4 | Cusabio | 5595 mg | Ask for price |
Recombinant Human Cancer/testis antigen 2 (CTAG2) |
|||
| CSB-EP006127HU | Cusabio | 915 mg | Ask for price |
Recombinant Human Cancer/testis antigen 2(CTAG2) |
|||
| AP70203 | SAB | 1mg | EUR 1978 |
Recombinant Human Cancer/testis antigen 2(CTAG2) |
|||
| AP77850 | SAB | each | Ask for price |
Human Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A3613 | BlueGene | 96T | EUR 700 |
Human Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01C2140-192T | BlueGene | 192 tests | EUR 1524 |
Human Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Human Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Human Cancer/testis antigen 1(CTAG1A) Elisa Kit |
|||
| EK712028 | AFG Bioscience LLC | 96 Wells | EUR 0.23 |
Human Cancer/testis antigen 1, CTAG1A ELISA KIT |
|||
| ELI-26802h | Lifescience Market | 96 Tests | EUR 988.8 |
Human Cancer/testis antigen 1 (CTAG1A) ELISA Kit |
|||
| AE48563HU-48Tests | Abebio | 48 Tests | EUR 325 |
Human Cancer/testis antigen 1 (CTAG1A) ELISA Kit |
|||
| AE48563HU-96Tests | Abebio | 96 Tests | EUR 610 |
Human Cancer/Testis Antigen 1 (CTAG1A) ELISA Kit |
|||
| abx259744-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human Cancer/testis antigen 1 (CTAG1A) ELISA Kit |
|||
| RK10621 | Abclonal | 96T | EUR 280 |
Human Cancer/Testis Antigen 1 (CTAG1A) ELISA Kit |
|||
| abx259744-1mg | Abbexa | 1 mg | Ask for price |
Human Cancer/Testis Antigen 1 (CTAG1A) ELISA Kit |
|||
| abx259744-20g | Abbexa | 20 µg | Ask for price |
Human Cancer/Testis Antigen 1 (CTAG1A) ELISA Kit |
|||
| abx259744-5g | Abbexa | 5 µg | EUR 687.5 |
CTAG1A (Myc-DDK-tagged)-Human cancer/testis antigen 1A (CTAG1A) |
|||
| RC216285 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Cancer / testis Antigen 1, CTAG1A GENLISA ELISA |
|||
| KBH6592 | Krishgen | 1 x 96 wells | EUR 286 |
Human CTAG1A / Cancer/testis antigen 1 ELISA Kit |
|||
| E13937h | EIAab | 96T | EUR 736 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| abx331930-100ul | Abbexa | 100 ul | EUR 510 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| 20-abx126874 | Abbexa |
|
|
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| 20-abx111352 | Abbexa |
|
|
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| abx027441-400ul | Abbexa | 400 ul | EUR 627.6 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| abx027441-80l | Abbexa | 80 µl | EUR 343.2 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| abx111352-100l | Abbexa | 100 µl | EUR 612.5 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
| abx027441-400l | Abbexa | 400 µl | EUR 518.75 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| RPU52916-100ug | Biomatik Corporation | 100ug | EUR 537.9 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| RPU52916-1mg | Biomatik Corporation | 1mg | EUR 2380.3 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| RPU52916-50ug | Biomatik Corporation | 50ug | EUR 431.2 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| RPJ316Hu01 | Cloud-Clone | 10ug | EUR 174 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| 4-RPJ316Hu01 | Cloud-Clone |
|
|
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| RPJ316Hu02 | Cloud-Clone | 10ug | EUR 176 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
|||
| RPJ316Hu03 | Cloud-Clone | 10ug | EUR 177 |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E02C2140-192T | BlueGene | 192 tests | EUR 1524 |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E02C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E02C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Dog Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E08C2140-192T | BlueGene | 192 tests | EUR 1524 |
Dog Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E08C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Dog Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E08C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Pig Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E07C2140-192T | BlueGene | 192 tests | EUR 1524 |
Pig Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E07C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Pig Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E07C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A12374 | BlueGene | 96T | EUR 700 |
Goat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A47286 | BlueGene | 96T | EUR 700 |
Goat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E06C2140-192T | BlueGene | 192 tests | EUR 1524 |
Goat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E06C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Goat Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E06C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Mouse Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E03C2140-192T | BlueGene | 192 tests | EUR 1524 |
Mouse Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E03C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Mouse Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E03C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Sheep Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A99580 | BlueGene | 96T | EUR 700 |
Mouse Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A21115 | BlueGene | 96T | EUR 700 |
Canine Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A64718 | BlueGene | 96T | EUR 700 |
Rabbit Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A29853 | BlueGene | 96T | EUR 700 |
Rabbit Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E04C2140-192T | BlueGene | 192 tests | EUR 1524 |
Rabbit Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E04C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Rabbit Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E04C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Monkey Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A73432 | BlueGene | 96T | EUR 700 |
Bovine Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A82151 | BlueGene | 96T | EUR 700 |
Monkey Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E09C2140-192T | BlueGene | 192 tests | EUR 1524 |
Monkey Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E09C2140-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Monkey Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E09C2140-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Porcine Cancer/testis antigen 1(CTAG1A) ELISA kit |
|||
| E01A56003 | BlueGene | 96T | EUR 700 |
- Subcutaneous injection of colon most cancers CD133+ cells readily reproduced the unique tumour in immunodeficient mice, whereas CD133- cells didn’t kind tumours. Such tumours had been serially transplanted for a number of generations, in every of which we noticed progressively sooner tumour progress with out important phenotypic alterations.
MONKEY CANCER/TESTIS ANTIGEN 1(CTAG1A) ELISA KIT
- Not like CD133- cells, CD133+ colon most cancers cells grew exponentially for a couple of yr in vitro as undifferentiated tumour spheres in serum-free medium, sustaining the flexibility to engraft and reproduce the identical morphological and antigenic sample of the unique tumour. We conclude that colorectal most cancers is created and propagated by a small variety of undifferentiated tumorigenic CD133+ cells, which ought to subsequently be the goal of future therapies.
